Search

Lei Yao

Examiner (ID: 12775, Phone: (571)272-3112 , Office: P/1642 )

Most Active Art Unit
1642
Art Unit(s)
1642
Total Applications
1328
Issued Applications
662
Pending Applications
127
Abandoned Applications
552

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 14213983 [patent_doc_number] => 20190119376 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-04-25 [patent_title] => ANTI-TIGIT ANTIBODIES AND METHODS OF USE [patent_app_type] => utility [patent_app_number] => 15/994583 [patent_app_country] => US [patent_app_date] => 2018-05-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 68721 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -30 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15994583 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/994583
ANTI-TIGIT ANTIBODIES AND METHODS OF USE May 30, 2018 Abandoned
Array ( [id] => 13566357 [patent_doc_number] => 20180334726 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-11-22 [patent_title] => SOMATIC MUTATIONS IN ATRX IN BRAIN CANCER [patent_app_type] => utility [patent_app_number] => 15/989820 [patent_app_country] => US [patent_app_date] => 2018-05-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4515 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -8 [patent_words_short_claim] => 50 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15989820 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/989820
Somatic mutations in ATRX in brain cancer May 24, 2018 Issued
Array ( [id] => 13607023 [patent_doc_number] => 20180355060 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-12-13 [patent_title] => Anti-Transglutaminase 2 Antibodies [patent_app_type] => utility [patent_app_number] => 15/987611 [patent_app_country] => US [patent_app_date] => 2018-05-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 34849 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15987611 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/987611
Anti-transglutaminase 2 antibodies May 22, 2018 Issued
Array ( [id] => 18414177 [patent_doc_number] => 11668715 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2023-06-06 [patent_title] => Biomarkers of disease [patent_app_type] => utility [patent_app_number] => 16/615687 [patent_app_country] => US [patent_app_date] => 2018-05-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 17345 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 207 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16615687 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/615687
Biomarkers of disease May 21, 2018 Issued
Array ( [id] => 15866337 [patent_doc_number] => 20200140572 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-05-07 [patent_title] => CONDITIONAL INTERNALIZATION OF PEGYLATED AGENTS BY PRETARGETING BI-SPECIFIC PEG-BINDING ANTIBODIES FOR DIAGNOSIS AND THERAPY [patent_app_type] => utility [patent_app_number] => 16/615822 [patent_app_country] => US [patent_app_date] => 2018-05-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5950 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -21 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16615822 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/615822
CONDITIONAL INTERNALIZATION OF PEGYLATED AGENTS BY PRETARGETING BI-SPECIFIC PEG-BINDING ANTIBODIES FOR DIAGNOSIS AND THERAPY May 8, 2018 Abandoned
Array ( [id] => 14326569 [patent_doc_number] => 10294288 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2019-05-21 [patent_title] => Peptides and combination of peptides for use in immunotherapy against esophageal cancer and other cancers [patent_app_type] => utility [patent_app_number] => 15/965305 [patent_app_country] => US [patent_app_date] => 2018-04-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 29 [patent_figures_cnt] => 31 [patent_no_of_words] => 52398 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 118 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15965305 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/965305
Peptides and combination of peptides for use in immunotherapy against esophageal cancer and other cancers Apr 26, 2018 Issued
Array ( [id] => 16429494 [patent_doc_number] => 10829561 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2020-11-10 [patent_title] => Antibodies targeting quiescin sulfhydryl oxidase (QSOX1) and uses of same [patent_app_type] => utility [patent_app_number] => 15/961928 [patent_app_country] => US [patent_app_date] => 2018-04-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 48 [patent_no_of_words] => 23120 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 35 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15961928 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/961928
Antibodies targeting quiescin sulfhydryl oxidase (QSOX1) and uses of same Apr 24, 2018 Issued
Array ( [id] => 17587726 [patent_doc_number] => 11325982 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2022-05-10 [patent_title] => Biparatopic and multiparatopic antibodies with common light chain and method of use [patent_app_type] => utility [patent_app_number] => 16/603711 [patent_app_country] => US [patent_app_date] => 2018-04-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 21 [patent_no_of_words] => 12686 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 155 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16603711 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/603711
Biparatopic and multiparatopic antibodies with common light chain and method of use Apr 8, 2018 Issued
Array ( [id] => 16176970 [patent_doc_number] => 20200223938 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-07-16 [patent_title] => ANTIBODY FC VARIANTS FOR INCREASED BLOOD HALF-LIFE [patent_app_type] => utility [patent_app_number] => 16/603273 [patent_app_country] => US [patent_app_date] => 2018-04-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10126 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -21 [patent_words_short_claim] => 57 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16603273 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/603273
Antibody Fc variants for increased blood half-life Apr 5, 2018 Issued
Array ( [id] => 15831987 [patent_doc_number] => 20200131275 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-04-30 [patent_title] => MULTISPECIFIC ANTIBODY CONSTRUCTS BINDING TO MUC1 AND CD3 [patent_app_type] => utility [patent_app_number] => 16/494566 [patent_app_country] => US [patent_app_date] => 2018-03-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19931 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 47 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16494566 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/494566
MULTISPECIFIC ANTIBODY CONSTRUCTS BINDING TO MUC1 AND CD3 Mar 26, 2018 Abandoned
Array ( [id] => 16799093 [patent_doc_number] => 10994008 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2021-05-04 [patent_title] => Modulation of tumor immunity [patent_app_type] => utility [patent_app_number] => 15/926035 [patent_app_country] => US [patent_app_date] => 2018-03-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 28 [patent_no_of_words] => 14382 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 176 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15926035 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/926035
Modulation of tumor immunity Mar 19, 2018 Issued
Array ( [id] => 19731134 [patent_doc_number] => 12209125 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2025-01-28 [patent_title] => Targeted gene integration of NK inhibitors genes for improved immune cells therapy [patent_app_type] => utility [patent_app_number] => 16/755082 [patent_app_country] => US [patent_app_date] => 2018-03-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 39 [patent_figures_cnt] => 39 [patent_no_of_words] => 35414 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 134 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16755082 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/755082
Targeted gene integration of NK inhibitors genes for improved immune cells therapy Mar 8, 2018 Issued
Array ( [id] => 16461101 [patent_doc_number] => 10844437 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2020-11-24 [patent_title] => Biomarkers for radiation treatment [patent_app_type] => utility [patent_app_number] => 15/913633 [patent_app_country] => US [patent_app_date] => 2018-03-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 12939 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 59 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15913633 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/913633
Biomarkers for radiation treatment Mar 5, 2018 Issued
Array ( [id] => 13413203 [patent_doc_number] => 20180258144 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-09-13 [patent_title] => CYTOTOXIC PROTEINS COMPRISING CELL-TARGETING BINDING REGIONS AND SHIGA TOXIN A SUBUNIT REGIONS FOR SELECTIVE KILLING OF SPECIFIC CELL TYPES [patent_app_type] => utility [patent_app_number] => 15/899428 [patent_app_country] => US [patent_app_date] => 2018-02-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 27299 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15899428 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/899428
CYTOTOXIC PROTEINS COMPRISING CELL-TARGETING BINDING REGIONS AND SHIGA TOXIN A SUBUNIT REGIONS FOR SELECTIVE KILLING OF SPECIFIC CELL TYPES Feb 19, 2018 Abandoned
Array ( [id] => 13051553 [patent_doc_number] => 10047158 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2018-08-14 [patent_title] => Anti-TIGIT antibodies and methods of use [patent_app_type] => utility [patent_app_number] => 15/895741 [patent_app_country] => US [patent_app_date] => 2018-02-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 24 [patent_figures_cnt] => 24 [patent_no_of_words] => 68726 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 40 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15895741 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/895741
Anti-TIGIT antibodies and methods of use Feb 12, 2018 Issued
Array ( [id] => 13457925 [patent_doc_number] => 20180280505 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-10-04 [patent_title] => METHODS AND COMPOSITIONS FOR TREATING CANCER USING PD-1 AXIS ANTAGONISTS AND HPK1 ANTAGONISTS [patent_app_type] => utility [patent_app_number] => 15/885040 [patent_app_country] => US [patent_app_date] => 2018-01-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 26294 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15885040 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/885040
METHODS AND COMPOSITIONS FOR TREATING CANCER USING PD-1 AXIS ANTAGONISTS AND HPK1 ANTAGONISTS Jan 30, 2018 Abandoned
Array ( [id] => 13826645 [patent_doc_number] => 20190016807 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-01-17 [patent_title] => ANTI-PD-L1 ANTIBODIES, COMPOSITIONS AND ARTICLES OF MANUFACTURE [patent_app_type] => utility [patent_app_number] => 15/881611 [patent_app_country] => US [patent_app_date] => 2018-01-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 61121 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -63 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15881611 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/881611
ANTI-PD-L1 ANTIBODIES, COMPOSITIONS AND ARTICLES OF MANUFACTURE Jan 25, 2018 Abandoned
Array ( [id] => 15191337 [patent_doc_number] => 10493139 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2019-12-03 [patent_title] => Humanized anti-CD19 antibody and use thereof with chimeric antigen receptor [patent_app_type] => utility [patent_app_number] => 15/876538 [patent_app_country] => US [patent_app_date] => 2018-01-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 14178 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 43 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15876538 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/876538
Humanized anti-CD19 antibody and use thereof with chimeric antigen receptor Jan 21, 2018 Issued
Array ( [id] => 13386397 [patent_doc_number] => 20180244740 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-08-30 [patent_title] => BH3 PEPTIDES AND METHODS OF USE THEREOF [patent_app_type] => utility [patent_app_number] => 15/869537 [patent_app_country] => US [patent_app_date] => 2018-01-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 20394 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15869537 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/869537
BH3 peptides and methods of use thereof Jan 11, 2018 Issued
Array ( [id] => 13369051 [patent_doc_number] => 20180236066 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-08-23 [patent_title] => METHODS OF TREATING CANCER USING PD-L1 AXIS BINDING ANTAGONISTS AND VEGF ANTAGONISTS [patent_app_type] => utility [patent_app_number] => 15/866325 [patent_app_country] => US [patent_app_date] => 2018-01-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18646 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -21 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15866325 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/866325
METHODS OF TREATING CANCER USING PD-L1 AXIS BINDING ANTAGONISTS AND VEGF ANTAGONISTS Jan 8, 2018 Abandoned
Menu